343269-52-3

Basic information

• Product Name: 5-Bromo-2-hydroxy-3-methylaniline
• Synonyms: 2-Amino-4-bromo-6-methylphenol;5-Bromo-2-hydroxy-3-methylaniline
• CAS NO: 343269-52-3
• Molecular Formula: C₇H₈BrNO
• Molecular Weight: 202.04852
• Mol File: 343269-52-3.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 5-Bromo-2-hydroxy-3-methylaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Bromo-2-hydroxy-3-methylaniline(343269-52-3)
• EPA Substance Registry System: 5-Bromo-2-hydroxy-3-methylaniline(343269-52-3)

Safety Data

• Hazardous Substances Data: 343269-52-3(Hazardous Substances Data)

Usage

General Description

5-Bromo-2-hydroxy-3-methylaniline is an organic compound that consists of a bromine atom, a hydroxy group, and a methyl group attached to a benzene ring. It is commonly used as an intermediate in the synthesis of various pharmaceuticals and dyes. 5-Bromo-2-hydroxy-3-methylaniline is categorized as a substituted aniline, and its structure gives it unique reactivity and properties that make it useful in a variety of chemical processes. 5-Bromo-2-hydroxy-3-methylaniline is also known for its potential as a starting material for the synthesis of specialty chemicals and advanced materials, making it an important compound in the field of organic chemistry.

Upstream product

• 20294-50-2 4-bromo-2-methyl-6-nitrophenol 
• 2362-12-1 4-Bromo-2-methylphenol 

Downstream Products

• 942215-51-2 5-bromo-7-methyl-2-(4-nitrophenyl)-1,3-benzoxazole 
• 1300745-37-2 C₁₄H₁₁BrN₂O₄ 
• 942215-50-1 2-(4-aminophenyl)-7-methyl-1,3-benzoxazole-5-carbonitrile 
• 942215-52-3 4-(5-bromo-7-methyl-1,3-benzoxazol-2-yl)aniline 
• 1268599-73-0 C₂₈H₂₅N₅O₄ 
• 1268599-72-9 C₃₀H₂₉N₅O₄ 
• 1268599-71-8 C₂₈H₂₅N₅O₄ 
• 1268599-70-7 C₂₉H₂₇N₅O₄ 
• 942214-09-7 C₂₇H₂₄ClN₅O₂ 
• 942214-12-2 C₂₈H₂₇N₅O₃ 
• 942214-11-1 C₂₈H₂₇N₅O₃ 
• 942211-78-1 C₂₇H₃₀N₄O₄ 
• 942211-77-0 C₂₈H₃₂N₄O₄ 

Relevant articles and documents

THERAPEUTIC COMPOUNDS AND METHODS OF USE

The invention relates to compounds and methods of using said compounds, as well as pharmaceutical compositions containing such compounds, for treating diseases and conditions mediated by TEAD, such as cancer.

SUBSTITUTED NITROGEN CONTAINING COMPOUNDS

Disclosed are compounds of Formula (I): or a salt thereof, Formula (II) wherein R1 is: or; each W is independently NR1b or O; Z is a bond or CHR1d; and R1, R2, Rd, R3a, R3b, L1, B, V, Y, and n are defined herein. Also disclosed are methods of using such compounds as inhibitors of ROMK, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating cardiovascular diseases.

NOVEL PDE4 INHIBITOR

Provided is a compound represented by formula (1a) or a pharmacologically acceptable salt thereof However, R 1 to R 6 in the formula each independently represent an alkyl group or the like.